With Q1 out, and revenue to be increasing, signing new
With Q1 out, and revenue to be increasing, signing new customers, not even having 75-85% of our technology out yet, we are looking good...really good. Looking for 5.8 mill + Q2 for a 45%+ increase in revenue over Q1. End of April Rory said Q2 will be even better, to know that then means we won’t just squeak by with 4.1 or 4.2 million. That’s not for three months so until then we will digest any new news we get, and there could be anything.
Info on any vertical
New customer signed up
New vertical(s)- our tech can be used for just about anything
Acquisition is a possibility, always a possibility, but not as likely now than in the second half of 2019, beginning 2020
Launch of our customer facing technology and what it looks like
Many many more things
8
TON Strategy Co. (TONX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...
Continue Reading
Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...
Continue Reading
A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...
Continue Reading
Top 5 Most Recently Viewed Articles
Samsung’s Ambitious AI Integration for Galaxy S26 Samsung Electronics SSNLF is actively pursuing partnerships with OpenAI and Perplexity AI as it strives to incorporate a wider array of artificial intelligence capabilities into its next-generation Galaxy devices. The company's intent is to diversify its AI services, significantly reducing its previous dependency on...
Continue Reading
Overview of Managers' Transactions at Orion Corporation Orion Corporation is committed to transparency and accountability in its operations. Recently, a disclosure was made concerning share transactions involving Eija Ronkainen, a notable member of the company's Board. This transaction is governed by the Market Abuse Regulation (EU) No 596/2014. Details of the Disclosure...
Continue Reading
Continuous Growth and Resilience in Tough Times Essity's recent interim report for the second quarter of 2025 showcases the company's ability to navigate through economic headwinds while maintaining a focus on growth and innovation. Even with a challenging economic backdrop, Essity demonstrated a stronger financial performance, indicating a commitment to both its...
Continue Reading
Lantheus Holdings and the Class Action Lawsuit Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently embroiled in a securities fraud class action lawsuit that has garnered attention from investors. This development comes after a shareholder filed a suit on behalf of those who acquired shares of the company between specific dates in 2025. Details of the Lawsuit The lawsuit...
Continue Reading
Ménage à Trois Introduces Light Sauvignon Blanc Fresh and flavorful, the Light Sauvignon Blanc from Ménage à Trois is set to delight consumers while catering to the growing demand for low-alcohol wines. With only 90 calories and 8% alcohol by volume, this new addition reflects the brand's commitment to providing products that align with modern lifestyles. Expanding...
Continue Reading